Despite some tangible results, characterised by a slow progressive decrease in the number of smokers, related to the gradual awareness of the population about the health effects of tobacco smoking, a large group of smokers cannot or do not want to give up tobacco smoking, and, eventually, one out of two lifelong smokers will die of smoking related illnesses.
The main goals of this Seminar are to describe what is known, unknown, knowable, and unknowable, and how any harm reduction policy could fit within "denormalisation" and the "mainstream" tobacco/nicotine control policy.
The role of nicotine in cigarette related morbidity
N. Benowitz (San Francisco, Ca, United States of America)
|   |
The role of the other components of cigarette smoke in cigarette related morbidity
F. Wiebel (Eching/Munchen, Germany)
| |
Nicotine addiction in animals : mechanisms and models
D. Balfour (Dundee, United Kingdom)
| |
Tobacco smoking as an addiction
K. Fagerström (Helsingborg, Sweden)
| |
What is harm reduction? Principles and observations from outside tobacco smoking
L. Gruer (Glasgow, United Kingdom)
| |
“Less harmful” cigarettes and new cigarette substitutes
D. Sweanor (Ottawa, Ontario, Canada)
| |
Smokefree tobacco
J. Foulds (New Brunswick, Nj, United States of America)
| |
Nicotine Replacement Therapy
J. Houezec (Rennes, France)
| |
The concept of “Recreational clean addictive nicotine”
N. Gray (Lyon, France)
| |
What is at stake? What are the possible gains and risks?
M. Laugesen (Auckland Region, New Zealand)
| |
What regulatory framework is preferable for successful harm reduction?
F. Godfrey (Luxemburg, Luxemburg)
| |
Proposals for future ; general discussion
Y. Martinet (Vandoeuvre-Les Nancy, France)
| |
How can Marketing help?
G. Hastings (Stirling, United Kingdom)
| |
Tobacco Smoking: Harm Reduction Strategies - An ERS Research Seminar
Ann McNeill, University College London
| |